{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:37:59Z","timestamp":1792521479387,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7520","license":[{"start":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T00:00:00Z","timestamp":1409270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T00:00:00Z","timestamp":1409270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2014,10,2]]},"DOI":"10.1038\/nature13777","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T05:09:04Z","timestamp":1409288944000},"page":"47-53","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":867,"title":["Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp"],"prefix":"10.1038","volume":"514","author":[{"given":"Xiangguo","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Audet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judie B.","family":"Alimonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Fausther-Bovendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Aviles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernie","family":"Hiatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsi","family":"Swope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ognian","family":"Bohorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Bohorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Pettitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene G.","family":"Olinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Whaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Zeitlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P.","family":"Kobinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,29]]},"reference":[{"key":"BFnature13777_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.antiviral.2008.01.152","volume":"78","author":"DG Bausch","year":"2008","unstructured":"Bausch, D. G., Sprecher, A. G., Jeffs, B. & Boumandouki, P. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. Antiviral Res. 78, 150\u2013161 (2008)","journal-title":"Antiviral Res."},{"key":"BFnature13777_CR2","doi-asserted-by":"publisher","unstructured":"Baize, S. et al. Emergence of Zaire Ebola virus disease in Guinea \u2014 preliminary report. N. Engl. J. Med. http:\/\/dx.doi.org\/10.1056\/NEJMoa1404505 (2014)","DOI":"10.1056\/NEJMoa1404505"},{"key":"BFnature13777_CR3","unstructured":"WHO. Ebola virus disease (EVD) http:\/\/www.who.int\/csr\/don\/archive\/disease\/ebola\/en\/ (accessed, 15 August 2014)"},{"key":"BFnature13777_CR4","unstructured":"CDC. Chronology of Ebola Hemorrhagic Fever Outbreaks, http:\/\/www.cdc.gov\/vhf\/ebola\/resources\/outbreak-table.html (accessed, 15 August 2014)"},{"key":"BFnature13777_CR5","unstructured":"Reliefweb. W. African Ebola epidemic \u2018likely to last months': UN http:\/\/reliefweb.int\/report\/guinea\/w-african-ebola-epidemic-likely-last-months-un (7 March 2014)"},{"key":"BFnature13777_CR6","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/v4091668","volume":"4","author":"DV Clark","year":"2012","unstructured":"Clark, D. V., Jahrling, P. B. & Lawler, J. V. Clinical management of filovirus-infected patients. Viruses 4, 1668\u20131686 (2012)","journal-title":"Viruses"},{"key":"BFnature13777_CR7","doi-asserted-by":"publisher","first-page":"S268","DOI":"10.1086\/514315","volume":"179","author":"Y Guimard","year":"1999","unstructured":"Guimard, Y. et al. Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 179 (Suppl. 1). S268\u2013S273 (1999)","journal-title":"J. Infect. Dis."},{"key":"BFnature13777_CR8","doi-asserted-by":"publisher","first-page":"S390","DOI":"10.1086\/520598","volume":"196","author":"LE Hensley","year":"2007","unstructured":"Hensley, L. E. et al. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J. Infect. Dis. 196 (Suppl 2). S390\u2013S399 (2007)","journal-title":"J. Infect. Dis."},{"key":"BFnature13777_CR9","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(03)15012-X","volume":"362","author":"TW Geisbert","year":"2003","unstructured":"Geisbert, T. W. et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa\/tissue factor: a study in rhesus monkeys. Lancet 362, 1953\u20131958 (2003)","journal-title":"Lancet"},{"key":"BFnature13777_CR10","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/S0140-6736(10)60357-1","volume":"375","author":"TW Geisbert","year":"2010","unstructured":"Geisbert, T. W. et al. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet 375, 1896\u20131905 (2010)","journal-title":"Lancet"},{"key":"BFnature13777_CR11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nm.2202","volume":"16","author":"TK Warren","year":"2010","unstructured":"Warren, T. K. et al. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nature Med. 16, 991\u2013994 (2010)","journal-title":"Nature Med."},{"key":"BFnature13777_CR12","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1371\/journal.ppat.0030002","volume":"3","author":"H Feldmann","year":"2007","unstructured":"Feldmann, H. et al. Effective post-exposure treatment of Ebola infection. PLoS Pathog. 3, e2 (2007)","journal-title":"PLoS Pathog."},{"key":"BFnature13777_CR13","doi-asserted-by":"publisher","first-page":"18030","DOI":"10.1073\/pnas.1213709109","volume":"109","author":"GG Olinger Jr","year":"2012","unstructured":"Olinger, G. G., Jr et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc. Natl Acad. Sci. USA 109, 18030\u201318035 (2012)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature13777_CR14","doi-asserted-by":"publisher","first-page":"138ra181","DOI":"10.1126\/scitranslmed.3003876","volume":"4","author":"X Qiu","year":"2012","unstructured":"Qiu, X. et al. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci. Transl. Med. 4, 138ra181 (2012)","journal-title":"Sci. Transl. Med."},{"key":"BFnature13777_CR15","doi-asserted-by":"publisher","first-page":"199ra113","DOI":"10.1126\/scitranslmed.3006608","volume":"5","author":"J Pettitt","year":"2013","unstructured":"Pettitt, J. et al. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci. Transl. Med. 5, 199ra113 (2013)","journal-title":"Sci. Transl. Med."},{"key":"BFnature13777_CR16","doi-asserted-by":"publisher","first-page":"207ra143","DOI":"10.1126\/scitranslmed.3006605","volume":"5","author":"X Qiu","year":"2013","unstructured":"Qiu, X. et al. mAbs and Ad-vectored IFN-\u03b1 therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms. Sci. Transl. Med. 5, 207ra143 (2013)","journal-title":"Sci. Transl. Med."},{"key":"BFnature13777_CR17","doi-asserted-by":"publisher","first-page":"14701","DOI":"10.1073\/pnas.0606631103","volume":"103","author":"A Giritch","year":"2006","unstructured":"Giritch, A. et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc. Natl Acad. Sci. USA 103, 14701\u201314706 (2006)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature13777_CR18","doi-asserted-by":"publisher","first-page":"S224","DOI":"10.1086\/514310","volume":"179","author":"PB Jahrling","year":"1999","unstructured":"Jahrling, P. B. et al. Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J. Infect. Dis. 179 (Suppl 1). S224\u2013S234 (1999)","journal-title":"J. Infect. Dis."},{"key":"BFnature13777_CR19","doi-asserted-by":"publisher","first-page":"e1575","DOI":"10.1371\/journal.pntd.0001575","volume":"6","author":"X Qiu","year":"2012","unstructured":"Qiu, X. et al. Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection. PLoS Negl. Trop. Dis. 6, e1575 (2012)","journal-title":"PLoS Negl. Trop. Dis."},{"key":"BFnature13777_CR20","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","volume":"287","author":"JA Wilson","year":"2000","unstructured":"Wilson, J. A. et al. Epitopes involved in antibody-mediated protection from Ebola virus. Science 287, 1664\u20131666 (2000)","journal-title":"Science"},{"key":"BFnature13777_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.clim.2011.08.008","volume":"141","author":"X Qiu","year":"2011","unstructured":"Qiu, X. et al. Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. Clin. Immunol. 141, 218\u2013227 (2011)","journal-title":"Clin. Immunol."},{"key":"BFnature13777_CR22","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1073\/pnas.1200409109","volume":"109","author":"JM Dye","year":"2012","unstructured":"Dye, J. M. et al. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc. Natl Acad. Sci. USA 109, 5034\u20135039 (2012)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature13777_CR23","doi-asserted-by":"publisher","first-page":"158ra146","DOI":"10.1126\/scitranslmed.3004582","volume":"4","author":"G Wong","year":"2012","unstructured":"Wong, G. et al. Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates. Sci. Transl. Med. 4, 158ra146 (2012)","journal-title":"Sci. Transl. Med."},{"key":"BFnature13777_CR24","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1073\/pnas.1209591110","volume":"110","author":"A Marzi","year":"2013","unstructured":"Marzi, A. et al. Antibodies are necessary for rVSV\/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates. Proc. Natl Acad. Sci. USA 110, 1893\u20131898 (2013)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature13777_CR25","unstructured":"ProMEDmail.org. Ebola virus disease - West Africa (117): WHO, Nigeria, Liberia, drug, more. http:\/\/www.promedmail.org\/direct.php?id=2666073 (6 August 2014)"},{"key":"BFnature13777_CR26","unstructured":"NC3RS. Practical blood sample volumes for laboratory animals, domestic species and non-human primates. http:\/\/www.nc3rs.org.uk\/bloodsamplingmicrosite\/page.asp?id=426 (accessed, 3 August 2014)"},{"key":"BFnature13777_CR27","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1038\/srep03365","volume":"3","author":"X Qiu","year":"2013","unstructured":"Qiu, X. et al. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Sci. Rep. 3, 3365 (2013)","journal-title":"Sci. Rep."},{"key":"BFnature13777_CR28","doi-asserted-by":"publisher","unstructured":"Wong, G. et al. Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents. Vaccine http:\/\/dx.doi.org\/10.1016\/j.vaccine.2014.08.028 (in the press)","DOI":"10.1016\/j.vaccine.2014.08.028"},{"key":"BFnature13777_CR29","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1086\/514298","volume":"179","author":"K Mupapa","year":"1999","unstructured":"Mupapa, K. et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J. Infect. Dis. 179 (Suppl. 1). S18\u2013S23 (1999)","journal-title":"J. Infect. Dis."},{"key":"BFnature13777_CR30","unstructured":"UPMChealthsecurity.org. Next-Generation Monoclonal Antibodies: Challenges and Opportunitieshttp:\/\/www.upmchealthsecurity.org\/our-work\/pubs_archive\/pubs-pdfs\/2013\/2013-02-04-next-gen-monoclonal-antibodies.pdf (UPMC Center for Biosecurity, 2013)"},{"key":"BFnature13777_CR31","doi-asserted-by":"publisher","first-page":"20690","DOI":"10.1073\/pnas.1108360108","volume":"108","author":"L Zeitlin","year":"2011","unstructured":"Zeitlin, L. et al. Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proc. Natl Acad. Sci. USA 108, 20690\u201320694 (2011)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature13777_CR32","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1086\/514305","volume":"179","author":"BM Connolly","year":"1999","unstructured":"Connolly, B. M. et al. Pathogenesis of experimental Ebola virus infection in guinea pigs. J. Infect. Dis. 179 (Suppl. 1). S203\u2013S217 (1999)","journal-title":"J. Infect. Dis."},{"key":"BFnature13777_CR33","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27, 493\u2013497 (1938)","journal-title":"Am. J. Hyg."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nature13777.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature13777","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature13777.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T15:12:49Z","timestamp":1659107569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature13777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,29]]},"references-count":33,"journal-issue":{"issue":"7520","published-print":{"date-parts":[[2014,10,2]]}},"alternative-id":["BFnature13777"],"URL":"https:\/\/doi.org\/10.1038\/nature13777","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718549062.793499579","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718549062.793517599","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,29]]},"assertion":[{"value":"5 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Her Majesty the Queen in right of Canada holds a patent on mAbs 2G4, and 4G7, PCT\/CA2009\/000070, \u201cMonoclonal antibodies for Ebola and Marburg viruses.\u201d K.W. and L.Z. are the owners of Mapp Biopharmaceutical Inc. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}